{
    "nct_id": "NCT03315975",
    "official_title": "Influenza Vaccine Responses in the Setting of Melanoma Treatment",
    "criteria": {
        "raw_text": "Inclusion Criteria:\n\n* adults capable of providing consent\n* have a diagnosis of locally advanced or metastatic melanoma\n\nExclusion Criteria:\n\n* are allergic to influenza vaccination\n* have received influenza vaccination within the past 6 months\n* require prednisone, methotrexate, or other immunosuppressing medications\n* have HIV infection\n* have a history of solid organ or bone marrow transplant\n* require combination immunotherapy\n* are on other studies requiring blood draws that might exceed 450 mL total during the period of the influenza vaccine study\n\nsex: ALL\n\nminimumAge: 18 Years\n\nstdAges: ['ADULT', 'OLDER_ADULT']",
        "inclusion": "* adults capable of providing consent\n* have a diagnosis of locally advanced or metastatic melanoma",
        "exclusion": "* are allergic to influenza vaccination\n* have received influenza vaccination within the past 6 months\n* require prednisone, methotrexate, or other immunosuppressing medications\n* have HIV infection\n* have a history of solid organ or bone marrow transplant\n* require combination immunotherapy\n* are on other studies requiring blood draws that might exceed 450 mL total during the period of the influenza vaccine study"
    }
}